CONGRUENCE

Serial Number 79397307
Registration 7830578
700

Registration Progress

Application Filed
May 2, 2024
Under Examination
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered
Jun 17, 2025

Trademark Image

CONGRUENCE

Basic Information

Serial Number
79397307
Registration Number
7830578
Filing Date
May 2, 2024
Registration Date
June 17, 2025
Published for Opposition
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 17, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

Congruence Therapeutics Inc.

99
Address
7171 Frederick-Banting, Suite 117
St-Laurent QC H4S 1Z9
CA

Ownership History

Congruence Therapeutics Inc.

Original Applicant
99
CA

Congruence Therapeutics Inc.

Owner at Publication
99
CA

Congruence Therapeutics Inc.

Original Registrant
99
CA

Legal Representation

Attorney
Kelsey A. Cloud

USPTO Deadlines

Next Deadline
2142 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-17)
Due Date
June 17, 2031
Grace Period Ends
December 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Jun 17, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 17, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 30, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 20, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 19, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 19, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 21, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 2, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 2, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 22, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 17, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 16, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 16, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 18, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jun 18, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treating rare diseases, metabolic diseases, and neurodegenerative diseases
Class 042
Scientific and medical research.
Class 044
Providing information relating to medical disorders, diagnosis and treatment options.

Classification

International Classes
005 042 044